News
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...
10don MSN
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention as a tool ...
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...
As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
Dailymotion on MSN2d
Ugandans hopeful for access to HIV injection drug, Lenacapavir
Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...
The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
8d
allAfrica.com on MSNKenya to Roll Out Long-Acting Injectable HIV Prep Lenacapavir By Jan 2026
Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results